Recurrence risks of hypertensive diseases in pregnancy after HELLP syndrome

Journal of Perinatal Medicine

Volumn 39, Issue 6, 2011, Pages 673-678

  Leeners, Brigitte ^a,b   Neumaier Wagner, Peruka M ^a   Kuse, Sabine ^c   Mütze, Sabine ^a   Rudnik Schöneborn, Sabine ^a   Zerres, Klaus ^a   Rath, Werner ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Arbeitsgemeinschaft Gestose Frauen eV   (Germany)

Author keywords

Gestational age; gestational hypertension; HELLP syndrome; pre eclampsia; pregnancy; recurrence risk

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEDICAL RECORD REVIEW; PREDICTION; PREECLAMPSIA; PRIMIGRAVIDA; PRIMIPARA; PRIORITY JOURNAL; PROTEINURIA; QUESTIONNAIRE; RECURRENCE RISK; THROMBOCYTE COUNT;

ADULT; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HELLP SYNDROME; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; PLATELET COUNT; PREGNANCY; QUESTIONNAIRES; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 80955130034     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2011.081     Document Type: Article

References (26)

1. Aardenburg R, Spaanderman MEA, Ekhart TH, van Eijndhoven HW, van der Heijden OWH, Peeters LLH. Low plasma volume following pregnancy complicated by pre-eclampsia predisposes for hypertensive disease in a next pregnancy. BJOG: an International Journal of Obstetrics and Gynaecology. 2003;110:1001-6.
2. Audibert F, Friedman SA, Frangieh AY, Sibai B. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1996;175:460-4.
3. Barton JR, Sibai BM. Care of the pregnancy complicated by HELLP syndrome. Gastroenterol Clin North Am. 1992;21: 937-50.
4. Broughton Pipkin F. Risk factors for pre-eclampsia. N Engl J Med. 2001;344:925-6.
5. Brown M, Lindheimer M, de Swiet M, Van Assche A, Moutquin J-M. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20:9-14.
6. Brown MA, Mackenzie C, Dunsmuir W, Roberts L, Ikin K, Matthews J, et al. Can we predict recurrence of pre-eclampsia or gestational hypertension? BJOG. 2007;114:984-93.
7. Chames MC, Haddad B, Barton JR, Livingston JC, Sibai BM. Subsequent pregnancy outcome in women with a history of HELLP syndrome at F28 weeks of gestation. Am J Obstet Gynecol. 2003;188:1504-8.
8. Committee W. Physical Status: the use and interpretation of anthropometry. WHO Technical Report; Series no.854. Geneva: WHO; 1995.
9. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, et al. Paternal and maternal components of the predisposition to pre-eclampsia. N Engl J Med. 2001;344: 867-72.
10. Geary M. The HELLP syndrome. Br J Obstet Gynaecol. 1997;104:887-91.
11. Hargood JL, Brown MA. Pregnancy-induced hypertension: recurrence rate in second pregnancies. Med J Aust. 1991;154:376-7.
12. Leeners B, Neumaier-Wagner P, Kuse S, Irawan C, Imthurn B, Rath W. Family stability during childhood and the risk to develop hypertensive diseases in pregnancy. Early Hum Dev. 2006;82:441-6.
13. Leeners B, Neumaier-Wagner P, Kuse S, Rath W. Smoking and the risk of developing hypertensive diseases in pregnancy: what is the effect on HELLP syndrome? Acta Obstet Gynecol Scand. 2006;85:1217-24.
14. Leeners B, Neumaier-Wagner P, Kuse S, Stiller R, Rath W. Emotional stress and the risk to develop hypertensive diseases in pregnancy. Hypertens Pregnancy. 2007;26:211-26.
15. Leeners B, Rath W, Kuse S, Irawan C, Imthurn B, Neumaier- Wagner P. BMI: New aspects of a classical risk factor for hypertensive disorders in pregnancy. Clin Sci (Lond). 2006; 111:81-6.
16. Roberts J, Redman W. Pre-eclampsia - more than pregnancy induced hypertension. Lancet. 1993;341:1447.
17. Roberts JM. Pre-eclampsia: What we know and what we do not know. Sem in Perinatol. 2000;24:24-8.
18. Sep SJ, Smits LJ, Prins MH, Spaanderman ME, Peeters LL. Simple prepregnant prediction rule for recurrent early-onset hypertensive disease in pregnancy. Reprod Sci. 2009;16: 80-7.
19. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med. 1996;335:257-65.
20. Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol. 1995;172:125-9.
21. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169:1000-6.
22. Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC,Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe pre-eclampsia-eclampsia. Am J Obstet Gynecol. 1986;155:501-9.
23. Sullivan CA, Magann EF, Perry KG Jr, Roberts WE, Blake PG, Martin JN Jr. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol.1994;171: 940-3.
24. van Pampus MG, Wolf H, Mayruhu G, Treffers PE, Bleker OP. Long-term follow-up in patients with a history of(H)ELLP syndrome. Hypertens Pregnancy. 2001;20:15-23.
25. van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset pre-eclampsia. Am J Obstet Gynecol. 2006;195: 723-8.
26. Zhang J, Troendle JF, Levine RJ. Risks of hypertensive disorders in the second pregnancy. Paediatr Perinat Epidemiol. 2001;15:226-31.